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ABSTRAK  
 
Tajuk: Kajian Kebarangkalian Pesakit Dengan Pendarahan Dalam Sistem 
“Ventricle” Yang Dirawat Dengan “External Ventricular Drainage” Berbanding 
Dengan “Endoskopic Washout” Yang  Memerlukan Shunt Untuk Aliran Cecair Otak : 
Kajian Intervensi dengan Control Historical 
 
Pengenalan: Pendarahan dalam system “ventricle” otak adalah entiti klinikal yang 
sering ditemui di hospital yang mempunyai perkhidmatan neurosurgeri. Keadaan ini 
biasanya disebabkan oleh pendarahan dalam otak primari yang akan melibatkan 
sistem “ventricle” dimana aliran cecair otak akan tergangu. Apabila keadaan ini 
berlaku dan aliran cecair otak tidak lancar, sistem “ventricle” akan kembang dan 
memyebabkan keadaan yang dikenali sebagai hydrocephalus. Seterusnya, ini 
menyebabkan peningkatan tekanan dalam otak dan memyebabkan pesakit berada 
dalam keadaan coma atau kurang sedar untuk jangka masa yang panjang. Selain itu, 
produk sampingan yang dihasilkan daripada pecahkan sel darah akan turut mengalir 
dalam cecair otak dan merosakkan “arachnoid granulations” dan menyebabkan 
hydrocephalus berkomunikasi lewat. Ahkirnya, semua ganguan ini akan menyumbang 
kepada morbiditi dan mortaliti pesakit yang 
terlibat. Pengurusan standard semasa IVH adalah 
dengan memasukkan saliran ventrikel luaran (EVD) kateter. Walau bagaimanapun, 
prosedur ini hanya menangani masalah hydrocephalus akut dan peningkatan tekanan 
otak. 
 
 
 
  xv 
 
Objektif: Tujuan kajian ini dijalankan adalah untuk membandingkan peratusan pesakit yang mengalami pendarahan dalam sistem ventricle yang dirawat dengan cara “endoscopic washout” banding dengan cara “external ventricular drainage” yang akhirnya memerlukan “shunt” untuk membantu dalam aliran cecair otak. Selain itu, kajian ini juga melihat perubahan dalam “Graeb skor” antara dua jenis rawatan ini. Graeb score adalah satu sistem untuk mengklasifikasikan pendarahan dalam ventricle dengan objective. Skor ini diterangkan dengan sepenuhnya di dalam proposal dissertasi yang disertakan. Tahap peningkatan dalam neurologi pesakit juga dikaji dalam masa 3 & 6 bulan. Neurologi pesakit akan diberi skor berdasarkan sistem “Modified Rankin Scale” dan peratusan pesakit yang mengalami jangkitan kuman selepas menerima rawatan yang dinayatakan akan dibandingkan antara 2 jenis rawatan yang diberi. Akhirnya, kajian ini mencari kaitan antara faktor pesakit seperti (umur, jantina, skor GCS asal masa pesakit diterima) dengan tahap neurology dalam masa 3 dan 6 bulan. 
 
Kaedah: Kami telah merawat 16 pesakit dengan pendarahan sistem “ventricle” 
otak dengan kaedah endoskopik washout sepertimana dinyatakan 
dalam protokol kajian untuk menangani semua sekuelanya yang tidak 
diingini disebabkan oleh keadaan neurosurgikal ini. 23 pesakit penyakit yang 
sama telah dirawat melalui saliran ventrikel luar (EVD). 
 
 
 
  xvi 
 
Keputusan: Semua pesakit yang dirawat dengan kaedah endoskopik washout pulih 
dengan baik dan hanya 3 pesakit memerlukan pembedahan lanjutan untuk meletak 
shunt dalam jangka masa 3 bulan. Terdapat perbezaan yang 
signifikan dalam kebergantungan kepada shunt untuk mengalirkan cecair otak di 
antara kedua-dua kawalan dan kumpulan intervensi (p-
0.004). Tempoh kebergantungan kepada kateter ventrikular luar (EVD) adalah jauh 
lebih pendek dalam kumpulan endoskopik wahout berbanding dengan kumpulan 
kateter ventrikular luar (p-0.007) Selain itu, pengurangan skor Graeb adalah lebih 
ketara dalam kumpulan endoskopik washout (p-0.001). 
 
Kesimpulan: Hasil yang baik diperoleh daripada kaedah endoskopik 
washout untuk pendarahan intraventricular yang serius mungkin berkaitan 
dengan penyingkiran awal hematoma, penciptaan baru lencongan laluan cecair otak, 
ditambah dengan jangka masa pendek yang diperlukan untuk kebergantungakan 
kepada kateter ventrikular luar (EVD) dan ventilator. Oleh 
itu, penggunaan neuroendoscopy pada pesakit dengan pendarahan intraventricular 
yang serius berjaya mengurangkan pergantungan kepada shunt dan dengan 
itu semua komplikasi yang berkaitan dengan shunt  juga dielakkan. 
 
Kata kunci: Pendarahan intraventricular serius, skor Graeb, kaedah endoskopik 
washout, arachnoid granulations  
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ABSTRACT 
 
 
Title: Prevalence of shunt dependence and clinical outcome in patients with massive 
intraventricular haemorrhage treated via endoscopic washout versus external ventricular 
drainage. 
 
Background: Intraventricular haemorrhage (IVH) is a commonly encountered 
neurosurgical emergency in most clinical centres. It is most prevalent in cases of 
hypertensive intracerebral haemorrhage (ICH) with extension into the ventricular 
system. This neurosurgical entity contributes to morbidity & mortality via blockage of 
ventricular conduits causing hydrocephalus and increased intracranial pressure, 
prolonged reduced level of consciousness and damage to the arachnoid granulations 
leading to delayed communicating hydrocephalus. Current standard management of 
IVH is by insertion of external ventricular drainage (EVD) catheter. However, this 
procedure only addresses the problem of acute hydrocephalus and raised ICP.  
 
Objective: The aim of this study is to evaluate the benefits of endoscopic washout 
surgery for treatment of massive intraventricular haemorrhage in terms of prevalence 
of drainage dependency, risks of external ventricular drain infection and to assess the 
functional outcome of the patient as compared to those treated via external ventricular 
drainage alone. 
 
  xviii 
Methods: We have treated 16 patients with massive IVH with endoscopic washout as 
per study protocol to address all the undesired sequelae caused by IVH. 23 patients of 
the same disease were treated via external ventricular drainage.  
 
Results: All patients treated with endoscopic washout recovered well and only 3 
patients required further shunt surgery at 3 months duration. There is significant 
difference in the shunt dependency between both control and intervention group (p-
0.004). The duration of weaning of the external ventricular catheter is significantly 
shorter in the endoscopic washout group (p-0.007) and the Graeb score reduction is 
significantly more in the endoscopic washout group (p-0.001).  
 
Conclusions: Good outcomes obtained from endoscopic washout for massive 
intraventricular haemorrhage may be related to early removal of hematomas, creation 
of new cerebrospinal diversion pathway, coupled with early weaning from external 
ventricular drain and ventilator. The use of neuroendoscopy in patients with massive 
IVH has significantly reduced the drainage dependency and therefore all shunt related 
complications are also avoided. 
 
Keywords: Massive intraventricular haemorrhage, Graeb score, endoscopic washout, 
arachnoid granulations 
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INTRODUCTION 
 
Intraventricular haemorrhage (IVH) is a commonly encountered neurosurgical 
emergency in most clinical centers. It is most prevalent in cases of hypertensive 
intracerebral haemorrhage (ICH) with extension into the ventricular system. The most 
common location for ICH is the striate body (putamen, lenticular nucleus, internal 
capsule and globus pallidus). This consists of the location of 50% of hypertensive 
ICH (Hamada et al., 2008). The next common location is the thalamus, which consists 
of 15%. Following an order of reducing frequency, subsequent locations would be 
pons, cerebellum, and white matter of cerebrum and finally followed by brainstem.  
 
Due to the anatomical proximity of the basal ganglia structures and thalamus with the 
ventricular system, most the hemorrhages will rupture thru the ventricular wall into 
the ventricular system and producing IVH. This occurs in almost 55% of cases. Many 
studies done previously have shown that the volume of IVH, presence of 
hydrocephalus, age and admitting GCS are among the predictors for mortality and 
functional outcome.  
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CHAPTER ONE: INTRAVENTRICULAR HAEMORRHAGE (IVH) 
 
 
 
1.1 Definition and pathogenesis of intraventricular haemorrhage 
 
Intraventricular haemorrhage denotes the presence of blood within the ventricular 
system of the brain. Intraventricular haemorrhage can be classified into primary or 
secondary types. Primary intraventricular hemorrhages are confined to the ventricular 
system and immediate parenchymal lining of the ependymal cells. Thus this bleed 
originates from intraventricular source or from a lesion that has very close proximity 
with the ventricular system. These consist of 30% of all cases of intraventricular 
hemorrhages (Anzai et al., 2000). Some of the common etiological factors that lead to 
primary intraventricular haemorrhage are head injury, arteriovenous malformation 
(AVM), aneurysmal bleed and presence of coagulopathy.  
 
Secondary intraventricular haemorrhage, on the other hand, originates as an extension 
of an intraparenchymal or subarachnoid haemorrhage into the ventricular system. 
These types of hemorrhages consist of 70% of all cases of intraventricular 
haemorrhage. Common causes of secondary IVH are hypertensive bleed (especially 
from the basal ganglia and thalamus), arteriovenous malformation (AVM), 
coagulopathy, vasculitic bleed, hemorrhagic transformation of ischemic infarct and 
tumours. It has been reported that the occurrence of IVH in cases of intracerebral or 
cerebellar haemorrhage significantly increases the rate of mortality.  
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1.2 Epidemiology of intraventricular haemorrhage 
 
Intraventricular haemorrhage is a common sequelae in patients with intracerebral 
haemorrhage (ICH). The most common location of bleed that causes extension into 
the ventricular system is the thalamus. Among all the cases of intracerebral 
haemorrhage, thalamic ICH is seen in 10-15% of cases (Chen et al., 2011a). The most 
common location for the occurrence of spontaneous intracerebral bleed is striate 
body, seen in up to 50% of patients (Hamada et al., 2008). Intraventricular 
haemorrhage is frequently encountered in patients with thalamic bleed because of its 
anatomical proximity to the third ventricle. 15-40% of patients with intracerebral 
haemorrhage will develop intraventricular haemorrhage (Ogura et al., 2006).  Simple 
comparison among patients who have intracerebral haemorrhage with or without 
intraventricular extension suggests that mortality substantially increased in those with 
intraventricular involvement. The mortality rate of intracerebral bleed patients is 20-
30%, and significantly increases to 50-80% when intraventricular extension is present 
(Staykov and Schwab, 2013). The presence of intraventricular hemorrhage is also 
associated with less than 20% good functional outcome as measured by the 90 and 
180-day modified Rankin scale (Rathor et al., 2012). 
 
The demographic pattern and data among Malaysian patients with intraventricular 
haemorrhage has not been previously studied. The study and analysis of functional 
outcome, morbidity and mortality among local population is challenging, as we are 
lacking the comprehensive database needed for such an analysis.  
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1.3 Risk factors for intraventricular haemorrhage 
 
Intraventricular haemorrhage is commonly seen in patients with intracerebral bleed, 
or known as haermorrhagic stroke. Intraventricular haemorrhage is rarely seen as a 
primary event, and almost always associated with presence of bleeding in another part 
of the brain. Therefore, to study the risk factors of intraventricular haemorrhage, it is 
usually associated with the risks of intracerebral haemorrhage.  
 
Generally, stroke can be categorized as ischemic or haermorrhagic. Ischemic stroke is 
more common with occurrence rate of 87%, and the remaining 13% constitutes 
haermorrhagic stroke (Kamikawa et al., 2001). This category of patients share similar 
risk factors to chronic vascular disease, namely age, hypertension, diabetes, 
hypercholestremia and cigarette smoking. Risk factors for stroke can be categorized 
into modifiable and non-modifiable risk factors. Non-modifiable risk factors are 
increasing age, male sex, family history of stroke and ethnicity. Modifiable risk 
factors include hypertension, diabetes mellitus, coronary heart disease, 
hyperlipidemia, obesity, atrial fibrillation, high dietary salt intake, cigarette smoking 
and alcohol abuse (MOH, 2011a). 
 
The incidence of intracerebral haemorrhage increases significantly after the age of 55 
years and doubles with each decade of age until age more than 80 years, where is 
incidence is 25 times that during the previous decade. The relative risk for age more 
than 70 years is 7. The relative risk of occurrence of intracerebral haemorrhage with 
alcohol consumption depends on the period of consumption with the amount 
consumed. In patients with alcohol consumed within 24 hours, the relative risk of 
 5 
intracerebral haemorrhage is 4.6 if the amount consumed is 41-120 gm EtOH and the 
risk escalates to 11.3 if more than 120 gm EtOH is consumed. For consumption 
period of 1 week prior to the onset of intracerebral haemorrhage, the relative risk is 2 
for average alcohol consumption of 1-150 gm EtOH, 4.3 if amount consumed is 151-
300 gm EtOH and 6.5 if more than 300 gm EtOH is consumed in that week (Gill et 
al., 1991). 
 
In Malaysia, diabetes mellitus and hypertension are the two main risk factors of 
strokes. The Fourth National Health and Morbidity survey in 2011 documented an 
increasing trend in risk factors for stroke. As many as  32.7 percent of Malaysians      
(5.8 million of the population) above the age of 18 years suffered from hypertension, 
a two-fold rise within a period of 10 years.   The prevalence of diabetes in Malaysia 
was noted to be 15.2%, (2.6 million of population), and obesity is at 15.1%. Data 
recorded in 2006 showed that smoking prevalence in Malaysia was 23.1% among 
adults (MOH, 2011b). This increasing prevalence, particularly among younger 
population age group increases the risk of development of artherothrombotic vascular 
disease, predisposing to younger age onset of stroke. 
 
Other causes of intraventricular haemorrhage consist of tumoural bleed, ruptured 
cerebrovascular aneurysm, bleeding from arteriovenous malformation (AVMs), post 
head injury, presence of coagulopathy, haemorrhagic transformation of ischemic 
stroke, and vasculitic bleed.  
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1.4 Pathophysiology of intraventricular haemorrhage 
Intraventricular haemorrhage occurs when the clot ruptures into the cerebral 
ventricular system thru the ependymal cell lining or as an extension of subarachnoid 
haemorrhage. The amount of blood that will be present depends on the balance 
between the coagulation cascade and the fibrinolytic pathway, which affects the 
amount of clot formation and dissolution of thrombus.  
 
1.4.1 The coagulation and fibrinolytic system 
Blood coagulation and fibrinolysis are initiated and modulated by compounds 
embedded in the external membrane of cells (tissue factor, thrombomodulin), 
deposited in extracellular matrix (heparin sulfate, dermatan sulfate, protease), or 
secreted by vascular cells in a regulated manner (von Willebrand factor, plasminogen 
activators, and plasminogen activator inhibitors). The hemostatic cascade is based 
upon the waterfall hypothesis of Ratnoff & Davies who published the sequence of 
proteolytic reactions starting with factor XII (Hageman factor) activation and ending 
with formed thrombin proteolyzing fibrinogen to form a clot (Ratnoff, 1988).  
 
Further in the mid-1970s, the cofactor for factor XII activation, prekalikrein and high-
molecular-weight- kininogen were identified and deficiencies of these proteins were 
not associated with a bleeding state (Saito et al., 1975). In 1977, Osterud and 
Rappaport recognized that factor VIIa is able to activate factor IX to factor IXa 
(Osterud and Rapaport, 1977). Later, Broze and colleagues recognized that the 
kinetics of tissue factor pathway inhibitor (TFPI) were such that under physiologic 
circumstances the factor VIIa–tissue factor complex cannot directly activate factor X 
but has to go through factor IX activation (Broze, 2003). These latter two studies 
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indicate the important role of the factor VIIa–tissue factor pathway for physiologic 
hemostasis.  
 
A key remaining question was how does factor XI, whose deficiency is associated 
with bleeding, become activated under physiologic circumstances. In 1991, Gailiani 
and Broze found that formed thrombin can activate factor XI, resulting in 
amplification of the coagulation system under stress (Badimon et al., 1991). 
Presently, physiologic hemostasis is believed to be an interacting system of activation 
and amplification of several zymogens that become serine proteases. The initiator of 
physiologic hemostasis is factor VIIa when bound to its cofactor tissue factor. 
Regulation of expression of tissue factor provides a major modulation of physiologic 
hemostasis. Thrombin in turn amplifies the process by activating factor XI, leading to 
additional factor IX activation.  
 
The fibrinolytic system's role is to lyse clot formed by thrombin. The anticoagulation 
system's role is to regulate all the enzymes of the coagulation and fibrinolytic systems 
so that there is no inappropriate excess of clotting or bleeding. 
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Figure 1.1: Coagulation and fibrinolytic system pathway with all the related clotting 
factors, cofactors and chemical molecules that can cause alteration in the pathway 
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1.4.2 Cerebral ventricular system 
The cerebral ventricular system provides a low-pressure pathway for the movement of 
cerebrospinal fluid. This system is frequently broken into when blood at near-systolic 
pressure passes thru a defect in the arterial wall, forming spontaneous intracerebral 
haemorrhage as it dissects the brain tissue (Qureshi et al., 2001). Cerebral 
haemorrhage can occur from defects in the vessel wall, such as aneurysms, 
arteriovenous malformation, vasculitic, impaired coagulation profile and hypertensive 
bleed. Therefore, multiple different diseases are capable of producing collection of 
blood that may occlude or obstruct the intraventricular space. Bleeding at the deep 
intracranial sites near to the ventricles leads to early intraventricular rupture and leads 
to sudden increase of intracranial pressure. This is commonly seen in thalamic or 
caudate nucleus haemorrhage. As for bleeding that occurs at sites that are further 
away from the ventricles will form clots and gradually accumulates and the increasing 
haemorrhage size produces rupture into the ventricular system.  
 
The actual rupture is often associated with reduced conscious level and can be 
recognized clinically. The subsequent sequelae is usually death if the condition is not 
intervened. The main aim of intervention is for rapid removal of clot and ICP 
monitoring which is aimed at moving the intraventricular haemorrhage from 
pathological domain into the clinical domain, which allows for qualitative and 
quantitative measurement of the pathology.  
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1.4.3 Clinical pathophysiology of intraventricular haemorrhage 
The clinical pathophysiology of intraventricular haemorrhage is described on how this 
neurosurgical condition leads to clinical outcome, morbidity and mortality. 
Intraventricular haemorrhage contributes to morbidity in 3 main ways (Hanley, 2009). 
Firstly, when haemorrhage occurs into the ventricular system, it will organize to form 
clots and will block the narrow parts of the ventricular conduits and hence produces 
acute hydrocephalus. If left untreated, acute hydrocephalus can cause elevation of the 
intracranial pressure, can progresses to death.  
 
At present, the management of IVH with presence of hydrocephalus entailed the 
placement of one or more external ventricular drainage for drainage of blood and CSF 
from the ventricular system and normalization of intracranial pressure. However, this 
approach alone may not be sufficient in improving the outcome of patients with IVH. 
One of the common problems encountered is to maintain the patency of the 
ventricular catheters. The catheters can be blocked easily by the blood clots and hence 
will defy the purpose of maintaining the intracranial pressure.  
 
Clinically, controlling ICP does not usually improve the patient immediately. Thus, 
direct mass effect from the IVH may be another significant pathophysiologic event 
independent of ICP elevation. This may suggest that placing an external ventricular 
catheter alone may not be sufficient as the mass effect from the blood clot may still 
persist after this procedure. Due to these issues, additional measures such as 
performing an endoscopic washout for patients with IVH prior to the placement of 
external ventricular drainage have been studied.  
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Secondly, the prolonged presence of clot deep within the brain is related to reduced 
level of consciousness and mortality. EVD does not consistently improve either event. 
This is because drainage alone does not alter the size of ventricles, brain tissue edema, 
and the inflammation provoked by the presence of intraventricular blood, and it does 
not increase the rate of blood clot resolution. To worsen the situation, placement of a 
drain is frequently complicated by infection such as meningitis and ventriculitis, and 
it also contributes to formation of new haemorrhage (Jernigan et al., 2014).  
 
Thirdly, the blood degradation products will flow via the CSF pathways to the 
arachnoid granulations. Prolonged contact of the blood breakdown products with the 
arachnoid granulations will lead to an inflammatory respond that permanently scars 
the granulations and causes delayed communicating hydrocephalus. When this 
condition occurs, the patient will require placement of a shunt for CSF diversion.  
 
It is still debatable whether by performing an endoscopic washout, it will prevent the 
damage of arachnoid granulations by blood degradation products and hence will not 
make the patient shunt dependent. However, there are not many studies done up-to-
date to establish and complement these findings. There are also no data available for 
the local population. 
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1.5 Clinical presentation of intraventricular haemorrhage 
The signs and symptoms of patients who present intraventricular haemorrhage can be 
generalized or focal. General symptoms are characterized by headache, nausea, 
vomiting, giddiness, loss of consciousness, and generalized seizures. These symptoms 
occur due to the sudden increase in intracranial pressure. As for the focal signs and 
symptoms, the clinical presentation depends on the location of the lesion, and on 
which neurovascular structures that are damaged.  
 
For patients who have intraventricular haemorrhage as an extension from cortical 
bleed, they present with transient ischemic attack (TIA) like symptoms in 50% of 
cases (Qureshi et al., 2001). However, unlike the typical TIAs, there is usually 
numbness, tingling sensation of the limbs, and progressively worsening weakness, in 
which either the upper or lower limbs are more affected than the other. The weakness 
and numbness progresses in a manner similar to a Jacksonian march pattern, 
corresponding to the motor and sensory homunculus. It may also spill over vascular 
territories, which is rather an electrical phenomenon rather than an ischemic or 
haemorrhagic event.  
 
The focal symptoms of patients with lobar haemorrhage with intraventricular 
extension depend on the involved lobe. Frontal lobe haemorrhage usually presents 
with frontal headache with contralateral hemiparesis, usually in the arms with mild 
weakness on the face and lower limb. The patient may also have frontal lobe 
syndrome, based on with part of the frontal lobes are affected. Parietal lobe 
involvement leads to contralateral hemisensory deficit with mild hemiparesis. When 
haemorrhage occurs in the occipital lobe, patient usually presents with ipsilateral eye 
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pain and contralateral homonymous hemianopia. Temporal lobe haemorrhage on the 
dominant hemisphere causes fluent dysphasia, with poor auditory comprehension but 
with relatively good repetition.  
 
Patients with putaminal haemorrhage, which the most common location for the 
development of spontaneous intracerebral haemorrhage, there will be smooth gradual 
deterioration in 62% of patients and the symptoms, are never fluctuating. The 
remaining 38% of patients presents with maximal neurological deficit at onset of ictus 
(Nagaratnam et al., 2001). Contralateral hemiparesis may progress to hemiplegia or 
even coma and death. Headache is seen in 14% of patients with putaminal 
haemorrhage, and 72% does not have headache at any time of the disease. 
Papilledema and subhyaloid preretinal haemorrhages are rarely present.  
 
As for patients with thalamic haemorrhage with intraventricular extension, the 
classical initial presentation is hemisensory loss, as thalamus is the main relay station 
for sensory modalities. When there is compression or extension of the bleed into the 
internal capsule, hemiparesis can occur. The hemiparesis is similar to putaminal 
haemorrhage type, but the contralateral sensory loss is striking and widespread. 
Extension into the upper brainstem (midbrain and upper pons) can also occur, and 
patient presents with vertical gaze palsy, convergence retraction nystagmus, skew 
deviation, loss of convergence, ptosis, miosis and anisocoria. Headache is observed in 
20-40% of patients with thalamic haemorrhage. Extension into the ventricular system 
is common in thalamic bleed, because of the anatomic proximity.  
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On the other hand, patients with cerebellar haemorrhage presents initially with signs 
and symptoms of increased intracranial pressure, the the compliance volume in the 
posterior fossa is small (15cm3) and obstructive hydrocephalus occurs early as a result 
of the 4th ventricle compression. Hydrocephalus can also result from the extension of 
the cerebellar haemorrhage into the ventricular system resulting in intraventricular 
haemorrhage. In addition to that, the patient may also present with signs and 
symptoms of direct brainstem compression. When the facial colliculus at the floor of 
4th ventricle is compressed, the patient presents with facial nerve palsy. Further 
worsening of the compression leads to loss of consciousness and comatose state due 
to the dysfunction of ascending reticular activating system (ARAS) fibers.  
 
Delayed deterioration after initial haemorrhage is usually caused by rebleeding (early 
or late), worsening of cerebral edema, hydrocephalus or seizures. Early rebleeding 
occurs within 24 hours from the onset of initial ictus. This is seen more commonly in 
patients with basal ganglia haemorrhage, and less common in lobar haemorrhages. 
The incidence of hematoma enlargement decreases with time, 33-38% in 1-3 hours, 
16% in 3-6 hours, and 14% within 24 hours. Patients with enlarging hematoma more 
likely to have presented with a large hematoma or has presence of coagulopathy. Late 
rebleeding from an initial intracerebral haemorrhage ranges from 1.8-5.3%, 
depending on the length of follow-up (Arakawa et al., 1998). Diastolic blood pressure 
was significantly higher in the group with recurrent haemorrhage with a 10%/year 
risk for DBP > 90mmHg versus less than 1.5%/year risk for DBP < 90mmHg. Other 
risk factors include diabetes, cigarette smoking and alcohol abuse. Recurrent 
haemorrhage may also indicate underlying vascular malformations or amyloid 
angiopathy. 
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Presence and worsening of edema and ischemic necrosis around the haemorrhage can 
also cause delayed deterioration. Although necrosis from mass effect of the clot 
contributes to a small part to the edema itself, the mass effect is insufficient to 
account for the amount of edema that occurs. The edema is caused by the release of 
edemogenic toxin as the clot is degraded (Badimon et al., 1991). Experiments with 
various components of blood clots have revealed that thrombin released from the clot 
causes increased permeability of the blood brain barrier and it is also a potent 
vasoconstrictor, which can worsen the ischemia.  
 
1.6 Imaging modalities in intraventricular haemorrhage 
Imaging plays an important role in the diagnosis and management of patient with 
intraventricular haemorrhage. The role of imaging is (1) to establish the diagnosis of 
intraventricular haemorrhage, as evidenced by presence of hyperdensity within the 
ventricular system, (2) to determine if the intraventricular haemorrhage is primary or 
secondary extension from another origin of clot, (3) to confirm presence of 
hydrocephalus and its degree of severity, (4) to objectively quantify clot volume, 
midline shift and patency of basal cisterns.  
 
The most common imaging modality that is performed is computed tomography (CT) 
scan. It remains the imaging modality of choice for the primary evaluation of 
intraventricular haemorrhage, as it is widely available in most hospitals 24 hours a 
day, is fast, reliable and safe. The objective of non-enhanced CT scan is similar with 
the role of imaging as mentioned above.  
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Typical appearance of intraventricular haemorrhage on CT scan is an area of 
hyperdensity within the ventricular system. In cases of secondary intraventricular 
haemorrhage, the location of the primary bleed can be visualized and the clot volume 
(Kothari et al., 1996) and extent of mass effect can be objectively calculated. (Figure 
1.1, 1.2) 
 
Magnetic resonance imaging (MRI) is usually not the procedure of choice for the 
initial study as it is not available in all hospitals. However, MRI is more sensitive than 
CT to very small amounts of blood, especially in the posterior fossa, where CT 
images are distorted by bony artifact. Both FLAIR and SWI sequence (especially at 3 
Tesla) are sensitive to small amounts of blood. Especially the latter will demonstrate 
tiny amounts of blood pooling in the occipital horns, and resulting in susceptibility 
induced signal drop out (Sohn et al., 2005). 
On FLAIR the signal intensity will vary depending on the timing of the scan. Within 
48 hours blood will appear as hyper-intense to the attenuated adjacent CSF. Later the 
signal is more variable and can be difficult to distinguish from flow related artifact 
(particularly in the third and fourth ventricles) unless other sequences are also used. 
 
Some of the disadvantages of MRI are imaging cost that is significantly higher than 
CT scanning. It is also difficult to ventilate and access patient during MRI as all the 
equipment must be compatible with the MRI scanner. The scanning time is also 
longer with MRI and it requires specialized interpretation of findings. Patient factors 
such as claustrophobia, cardiac pacemaker and metal implants also need to be 
considered.                                                                  
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1.7 Scoring system for intraventricular haemorrhage 
As with any other intracranial pathology, there is an objective system to score the 
severity of intraventricular haemorrhage. At present, there are two widely acceptable 
grading systems in the literatures, which are Graeb grading & LeRoux grading (Graeb 
et al., 1982). In Graeb grading of intraventricular haemorrhage, the score ranges from 
2-12. The score is a product of addition of the component scores that is given to the 
lateral ventricles, 3rd and 4th ventricles. Presence of blood in the lateral ventricles are 
given score of 1 if there is only traces of blood, 2 if less than ½ of ventricle filled with 
blood, 3 if more than ½ is filled with blood and 4 when the ventricles are filled with 
blood and expanded. As for the 3rd and 4th ventricles, score 0 is given when there are 
no blood in the 3rd and 4th ventricle, score of 1 indicates that blood is present, but the 
Figure 1.3: CT findings of secondary 
intraventricular haemorrhage as an 
extension of right basal ganglia bleed 
                                                         
Figure 1.2: CT findings of primary 
intraventricular haemorrhage,  
the hematoma is confined to the  
ventricular system           
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ventricle size is normal and score of 2 is given when the 3rd and 4th ventricles are 
filled with blood and expanded.  
 
As for the LeRoux grading, all the ventricles are scored evenly, from 1-4 and then 
each of the component scores are added to get the final result. Score of 1 is given 
when there are only traces of blood, 2 if only less than ½ the ventricles are filled with 
blood, 3 if more than ½ is filled with blood and 4 when the ventricles are filled with 
blood and expanded (LeRoux et al., 1992). Any score of more than 6, obtained via the 
Graeb or Le Roux grading system is defined as massive intraventricular haemorrhage. 
 
The presence of hydrocephalus in patients with intraventricular haemorrhage is 
commonly seen, as the blood clot causes blockage to the normal CSF pathways. To 
grade the severity of hydrocephalus, Diringer has formulated a scoring system, which 
scores the lateral ventricle, 3rd and 4th ventricles. As for the lateral ventricles, it is 
further scored in 3 different locations (frontal horn, atrium and temporal horn). Each 
of these component is given score of 0-3, in which 0 represents normal shape of the 
ventricle, 1 mean mild hydrocephalus, 2 for moderate and 3 when there is rounding of 
the ventricular wall or presence of sulcal effacement. The maximum score for the 
Diringer grading of hydrocephalus is 24 (Diringer et al., 1998).  
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Table 1.1 Graeb grading system for intraventricular haemorrhage (Graeb et al., 1982) 
Location of 
clot 
Trace of 
blood 
Less than 50% 
filled 
More than 
50% filled 
Completely filled 
and expanded 
Lateral 
ventricles 
1 2 3 4 
Location of 
clot 
No blood 
present 
Blood present, 
ventricle 
normal size 
Filled with 
blood and 
expanded 
_ 
3rd ventricle 0 1 2 _ 
4th ventricle 0 1 2 _ 
* The total score is the addition of both lateral ventricles score, 3rd ventricle score  
   and 4th ventricle score (Score range 2-12) 
 
 
Table 1.2 Le Roux grading system for intraventricular haemorrhage (LeRoux et al., 
1992) 
Location of 
clot 
Trace of 
blood 
Less than 50% 
filled 
More than 
50% filled 
Completely filled 
and expanded 
Lateral 
ventricles 
1 2 3 4 
3rd ventricle 1 2 3 4 
4th ventricle 1 2 3 4 
* The total score is the addition of both lateral ventricles score, 3rd ventricle score  
   and 4th ventricle score (Score range 4-16) 
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Table 1.3 Diringer grading system for hydrocephalus (Diringer et al., 1998) 
Score 0 1 2 3 
Frontal horn No Mild Moderate Rounding, sulcal effacement 
Atrium No Mild Moderate Rounding, sulcal effacement 
Temporal horn No Mild Moderate Increased width 
3rd ventricle No Mild Moderate Ballooning 
4th ventricle No Mild Moderate Ballooning 
* Score range 0-24 
 
1.8 Treatment options for intraventricular haemorrhage 
The treatment option for intraventricular haemorrhage is directed towards the removal 
of blood clots and cerebrospinal fluid from the ventricular system in order to 
normalize intracranial pressure. Generally, the management options that are available 
includes (1) placement of external ventricular drainage (EVD) catheters, 
(2) conventional craniotomy and clot evacuation, (3) external ventricular drainage 
with adjunctive thrombolytics and (4) endoscopic washout of the intraventricular 
haemorrhage.  
 
Traditionally, the treatment of intraventricular haemorrhage has entailed the 
placement of one or more external ventricular drains to allow blood clots and 
cerebrospinal fluid to flow out from the ventricles. This will lead to normalization of 
the intracranial pressure. However, this approach alone is often not sufficiently 
effective in improving the poor prognosis of massive intraventricular haemorrhage 
(Onem et al., 2007). External ventricular drains only address one of the acute 
consequences of intraventricular haemorrhage, which is acute obstructive 
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hydrocephalus. The catheter often becomes occluded because of thick blood clots, and 
results in failure of drainage (Kiymaz et al., 2005). When this happens, the 
conventional therapy is removal of the occluded catheter and insertion of a second 
catheter in another location, preferably one that is free of blood. Relocation of the 
external ventricular drain carries a low but clinically significant risk of intracerebral 
haemorrhage, and is often unsuccessful as the drain can reliably access only a portion 
of the ventricles. If the accessible portion is occupied by blood, then the newly placed 
external ventricular drain will likely occlude.  
 
For many patients, drainage is unsuccessful and they succumb to obstructive 
hydrocephalus. Even when drainage is successful, persistent blood clots increase the 
time that drainage is needed, thus increasing the risk of ventriculitis, which is about 
16% when blood is in the ventricle (Fabiano et al., 2013). At least three factors are 
associated with increased risk of ventriculitis: presence of blood within the ventricular 
system, duration of catheterization, and irrigation of the external ventricular drainage 
system (Lozier et al., 2008). 
 
External ventricular drainage alone does not alter the rate of intraventricular clot 
resolution or impact the effect of blood on deep periventricular brain tissue edema 
generation and the accompanying progressive cell death. External ventricular drains 
cannot remove the blood clot, relieve local tissue compression from distended 
ventricles, or alter the rate of blood clot resolution (Naff et al., 2001). It also does not 
shorten the time that the blood clot is in contact with the ventricular system and deep 
brain structures. 
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Although the placement of external ventricular drain is helpful in controlling 
increased intracranial pressure, the blood clots must be cleared from the cerebrospinal 
fluid conduits by the patients’ own fibrinolysis mechanism. Furthermore, external 
ventricular drains fails to decrease the degree and incidence of communicating 
hydrocephalus, because it does not hasten the resolution of the intraventricular blood 
clot which leads to the pathomechannics of the development of communicating 
hydrocephalus. Delayed communicating hydrocephalus is caused by an inflammatory 
reaction generated by fibrin degradation products, which is formed during clot 
resolution. This will render the patient drainage dependent and requires surgery for 
shunt insertion, leaving the patient with lifelong risk of shunt infection, malfunction 
and occlusions (Li et al., 2013).  
 
Another potential treatment modality is surgical evacuation of clot via conventional 
craniotomy, which is mainly performed in patients with intracerebral haemorrhage. 
Surgical craniotomy with clot evacuation has been shown to increase the percentage 
of intracerebral haemorrhage volume reduction in the first 24 hours when compared 
with best medical therapy (76% versus 0%). However, craniotomy has not been 
shown to improve the 30-day outcome as measured by Glasgow Outcome Scale when 
compared with best medical therapy (Zuccarello et al., 1999). With regard to 
intraventricular haemorrhage, standard craniotomy and clot evacuation has several 
limitations. Firstly, complete surgical removal of the blood clot is hazardous and even 
impossible if it involves all the ventricles. Secondly, craniotomy is a major surgery 
and associated with high morbidity rate. Third, surgery may worsen the cerebral 
edema and hence lead to increased intracranial pressure.  
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Therefore, with these risks and benefits in mind, the best management should not be 
as conservative as an external ventricular drain placement, nor shall it be as 
aggressive as a conventional craniotomy and clot evacuation. These has raised interest 
in the utilization of neuroendoscopy for ventricular clot evacuation and hence 
reduction in the intracranial pressure. Massive intraventricular haemorrhage requires 
aggressive and rapid management to reduce the intracranial hypertension. The amount 
of intraventricular blood is a strong prognostic factor, in terms of morbidity and 
mortality. Therefore, fast removal of the clot should be considered a priority. 
 
1.9 Outcome following intraventricular haemorrhage 
The outcome of patient with intraventricular bleed is predicted by its severity at 
presentation. If untreated, the mortality rate of patients with intraventricular 
haemorrhage ranges from 50% to 80%. In patients who undergo surgical management 
(external ventricular drainage or endoscopic washout) the 30 and 90-day mortality 
rate is 12.5% and 20.8% respectively, with no significant difference between the 2 
groups. Patient factor such as age and initial GCS on arrival has significant impact on 
the functional outcome, as measured by modified Rankin scale.  
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CHAPTER TWO: BACKGROUND OF STUDY 
 
2.1 External ventricular drainage for intraventricular haemorrhage 
The placement of one or more external ventricular drains to allow blood clots and 
cerebrospinal fluid to flow out from the ventricles. This will lead to normalization of 
the intracranial pressure. However, this approach alone is often not sufficiently 
effective in improving the poor prognosis of massive intraventricular haemorrhage 
(Basaldella et al., 2012). External ventricular drains only address one of the acute 
consequences of intraventricular haemorrhage, which is acute obstructive 
hydrocephalus. The catheter often becomes occluded because of thick blood clots, and 
results in failure of drainage. 
 
For many patients, drainage is unsuccessful and they succumb to obstructive 
hydrocephalus. Even when drainage is successful, persistent blood clots increase the 
time that drainage is needed, thus increasing the risk of ventriculitis, which is about 
16% when blood is in the ventricles (Fabiano et al., 2013). At least three factors are 
associated with increased risk of ventriculitis: presence of blood within the ventricular 
system, duration of catheterization, and irrigation of the external ventricular drainage 
system (Lozier et al., 2008). 
 
 
 
 
